Discloses a cyclic peptide of formula I or II with R groups as disclosed including all enantiomers, sterioisomers or diastereoisomers thereof, or a pharmaceutically acceptable salt. Discloses the use of the cyclic peptide for use in the manufacture of a medicament for treatment of melanocortin receptor mediated disease or for the treatment of male or female sexual dysfunction.
